Trader’s Buzzer: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.25% or -0.08 points to reach at $32.52 during previous trading session. The stock’s price fluctuated within the range of $32.33 – $32.78 during previous trading session. A total of 20,274,122 shares exchanged hands, whereas the company’s average trading volume stands at 26.85M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $196.86B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 46.17.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 14 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is -0.99% whereas its distance from 50 day simple moving average is 1.48% along with -2.14% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -11.43% below from the 52-week high mark of $36.72 and +18.28% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -2.87% in the past one week and plunged -0.94% during previous one month drive, the stock went up 0.26% during past quarter. In the last six months the stock’s performance fell -9.93% while yearly performance of the company advanced 8.49%. The company’s year to date (YTD) performance is at 0.12%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.49, along with its weekly and monthly volatility of 1.56%, 1.24% respectively. Beta value of the stock stands at 0.94.

The company’s price to free cash flow for trailing twelve months is 111.08. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Investor’s Alert: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.09% or -0.03 points to reach at $33.44 during previous trading session. The stock’s price fluctuated within the range of $33.32 – $33.66 during previous trading session. A total of 19,368,800 shares exchanged hands, whereas the company’s average trading volume stands at 6.07B shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $202.87B and most recently 26.22M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 63.69.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 14 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 2.12% whereas its distance from 50 day simple moving average is 4.60% along with 0.80% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -8.92% below from the 52-week high mark of $36.72 and +21.63% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 1.33% in the past one week and soared 8.08% during previous one month drive, the stock went up 0.49% during past quarter. In the last six months the stock’s performance fell -6.03% while yearly performance of the company advanced 11.70%. The company’s year to date (YTD) performance is at 2.96%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.44, along with its weekly and monthly volatility of 1.13%, 1.28% respectively. Beta value of the stock stands at 0.94.

The company’s price to free cash flow for trailing twelve months is 114.38. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock in Limelight: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.03% or -0.01 points to reach at $32.48 during previous trading session. The stock’s price fluctuated within the range of $32.31 – $32.60 during previous trading session. A total of 18.87M shares exchanged hands, whereas the company’s average trading volume stands at 23.86M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $197.04B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 56.31.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 0.87% whereas its distance from 50 day simple moving average is 2.05% along with -1.73% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -11.54% below from the 52-week high mark of $36.72 and +18.13% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.43% in the past one week and soared 1.06% during previous one month drive, the stock went down -3.15% during past quarter. In the last six months the stock’s performance fell -7.01% while yearly performance of the company advanced 4.42%. The company’s year to date (YTD) performance is at 4.42%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.45, along with its weekly and monthly volatility of 0.82%, 1.44% respectively. Beta value of the stock stands at 0.90.

The company’s price to free cash flow for trailing twelve months is 110.63. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock on Trader’s Radar: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.19% or -0.06 points to reach at $32.34 during previous trading session. The stock’s price fluctuated within the range of $32.05 – $32.43 during previous trading session. A total of 18,582,400 shares exchanged hands, whereas the company’s average trading volume stands at 26.40M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $193.56B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 52.60.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 0.98% whereas its distance from 50 day simple moving average is 1.62% along with -1.89% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -11.92% below from the 52-week high mark of $36.72 and +17.62% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -1.25% in the past one week and soared 3.22% during previous one month drive, the stock went down -4.66% during past quarter. In the last six months the stock’s performance fell -3.05% while yearly performance of the company advanced 3.08%. The company’s year to date (YTD) performance is at 3.97%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.54, along with its weekly and monthly volatility of 1.21%, 1.60% respectively. Beta value of the stock stands at 0.90.

The company’s price to free cash flow for trailing twelve months is 110.15. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock to Keep Your Eyes on: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price soared 0.27% or +0.09 points to reach at $32.84 during previous trading session. The stock’s price fluctuated within the range of $32.52 – $32.94 during previous trading session. A total of 36,843,862 shares exchanged hands, whereas the company’s average trading volume stands at 25.93M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $198.86B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 59.87.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.85. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $33.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 15 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 3.32% whereas its distance from 50 day simple moving average is 3.08% along with -0.14% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -10.56% below from the 52-week high mark of $36.72 and +19.44% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 3.60% in the past one week and soared 2.75% during previous one month drive, the stock went down -1.43% during past quarter. In the last six months the stock’s performance fell -3.06% while yearly performance of the company advanced 5.42%. The company’s year to date (YTD) performance is at 5.58%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.70, along with its weekly and monthly volatility of 1.71%, 1.69% respectively. Beta value of the stock stands at 0.89.

The company’s price to free cash flow for trailing twelve months is 111.85. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Notable Mover: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price soared 2.46% or +0.76 points to reach at $31.70 during previous trading session. The stock’s price fluctuated within the range of $31.09 – $31.92 during previous trading session. A total of 29.35M shares exchanged hands, whereas the company’s average trading volume stands at 32.99M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $195.51B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 50.25.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.85. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $33.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 15 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is -0.29% whereas its distance from 50 day simple moving average is -0.77% along with -3.36% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -13.66% below from the 52-week high mark of $36.72 and +15.30% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.22% in the past one week and plunged -1.31% during previous one month drive, the stock went down -7.60% during past quarter. In the last six months the stock’s performance fell -7.07% while yearly performance of the company advanced 1.67%. The company’s year to date (YTD) performance is at 1.92%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.73, along with its weekly and monthly volatility of 1.81%, 1.90% respectively. Beta value of the stock stands at 0.91.

The company’s price to free cash flow for trailing twelve months is 107.97. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock to Watch: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged 0.54% or +0.17 points to reach at $31.63 during previous trading session. The stock’s price fluctuated within the range of $31.36– $31.73 during previous trading session. A total of 19.01M shares exchanged hands, whereas the company’s average trading volume stands at 31.61M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $187.88B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 47.43.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $37.76. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $33.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 15 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 3 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.61B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.37B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.27 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 5 have given the stock a Buy while 6 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 0.34% whereas its distance from 50 day simple moving average is -1.69% along with -3.42% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -13.85% below from the 52-week high mark of $36.72 and +15.04% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -0.19% in the past one week and soared 4.29% during previous one month drive, the stock went down -8.12% during past quarter. In the last six months the stock’s performance fell -7.78% while yearly performance of the company advanced 1.35%. The company’s year to date (YTD) performance is at 1.69%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.68, along with its weekly and monthly volatility of 1.61%, 2.11% respectively. Beta value of the stock stands at 0.89.

The company’s price to free cash flow for trailing twelve months is 107.77. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Trader’s Buzzer: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.27% or -0.08 points to reach at $30 during previous trading session. The stock’s price fluctuated within the range of $29.96 – $30.45 during previous trading session. A total of 35.45M shares exchanged hands, whereas the company’s average trading volume stands at 22.44M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $ 184.27B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 23.72.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $37.86. The most optimistic analyst sees the stock reaching $53 while the most conventional predicts the target price at $33.

The consensus mean EPS for the current quarter is at $0.51 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.6. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.64 per share according to consensus of 3 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.66B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.37B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.27 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 5 have given the stock a Buy while 6 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is -6.11% whereas its distance from 50 day simple moving average is -9.82% along with -8.58% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -19.10% below from the 52-week high mark of $37.08 and +8.04% above from the 52-week bottom of $27.77. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -3.44% in the past one week and plunged -10.74% during previous one month drive, the stock went down -14.60% during past quarter. In the last six months the stock’s performance fell -8.78% while yearly performance of the company fell -8.39%. The company’s year to date (YTD) performance is at -4.50%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.50, along with its weekly and monthly volatility of 1.91%, 1.43% respectively. Beta value of the stock stands at 0.90.

Tracking Earnings for Pfizer Inc. (NYSE:PFE)

Shares of Pfizer Inc. (NYSE:PFE) fell -2.02% to reach at $31.07 during previous trading session. The company has experienced volume of 54.35M shares while on average the company has a capacity of trading 18.98M share.

Pfizer Inc. (NYSE:PFE) on November 1, 2016 reported financial results for third-quarter 2016 and narrowed certain 2016 financial guidance ranges.

On September 3, 2015, Pfizer acquired Hospira, Inc. (Hospira). Consequently, financial results for the third quarter and first nine months of 2016 include legacy Hospira global operations while financial results for the third quarter and first nine months of 2015 include only one month of legacy Hospira U.S. operations but no financial results from legacy Hospira international operations.

On June 24, 2016, Pfizer acquired Anacor Pharmaceuticals, Inc. (Anacor). Therefore, financial results for the third quarter and first nine months of 2016 reflect approximately three months of legacy Anacor operations, which were immaterial.

On September 28, 2016, Pfizer acquired Medivation, Inc. (Medivation). Therefore, financial results for the third quarter and first nine months of 2016 reflect three business days of legacy Medivation operations, which were immaterial.

The Company manages its commercial operations through two distinct businesses: Pfizer Innovative Health (IH) (formerly the Innovative Products business) and Pfizer Essential Health (EH) (formerly the Established Products business).

On November 1, 2016, Pfizer announced the decision to discontinue development of bococizumab. As a result, 2016 financial guidance for Adjusted R&D expenses was negatively impacted by $0.3 billion and Adjusted Diluted EPS was negatively impacted by $0.04.

Pfizer Inc. (NYSE:PFE) holds the market capitalization of $187.16B along with 6.07B outstanding shares. During the last trade, stock’s minimum price has been reached out at $30.75 while the maximum trading price moved at $31.72. Currently the stock price is moving -16.21% off from the highest level of twelve months and +11.89% above from twelve months low. Pfizer Inc. (NYSE:PFE) marked 52-week highest price level of $37.08 on 08/01/16 and 52-week lowest price level of $27.77 on 02/08/16. For the stock, price target value has been calculated at $38.74 based on calls of 19 experts. Stock’s minimum price target estimates has been figured out at $33.00 while the maximum price target forecast is established at $54.00.

As of current trade, Pfizer Inc. (NYSE:PFE) has shown weekly downbeat performance of -3.75%. Its six months performance indicated a bearish movement while its yearly performance reflected a negative trend of -8.20%. Year-to-date (YTD) performance of the stock illustrate downbeat trend of -1.09%. Shares of Pfizer Inc. (NYSE:PFE) currently have an ABR of 2.08, derived from a total of 13 opinions. The company’s price sits -7.84% below from its 50-day moving average of $33.20 and -5.27% below from the stock’s 200-day moving average of $34.37. The company has Relative Strength Index (RSI 14) of 22.81 along with Average True Range (ATR 14) of 0.47. Its weekly and monthly volatility is 1.88%, 1.24% respectively. The company’s beta value is at 0.89.

Pfizer Inc. (NYSE:PFE) currently has a PEG ratio of 4.45 where as its P/E ratio is 27.57. The company’s price to sales ratio for trailing twelve months is 3.61 and price to book ratio for most recent quarter is 3.00, whereas price to cash per share for the most recent quarter is 9.00. Pfizer Inc. (NYSE:PFE)’s price to free cash flow for trailing twelve months is 31.17. Its quick ratio for most recent quarter is 1.10 along with current ratio for most recent quarter of 1.40. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.49. Pfizer Inc. (NYSE:PFE) has a Return on Assets of 4.20%. The company currently has a Return on Equity of 10.90% and Return on Investment of 7.30%.

Analysts Concerns on: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) fell -0.94% during previous trade. Jefferies issued rating on the stock of Pfizer Inc. (NYSE:PFE) in a research note issued to investors on Oct-13-16, the stock received “Downgrade” rating from Buy to Hold. Additionally Jefferies issued their verdict on the stock of the company, on record date of Jun-20-16 the stock was “Reiterated” as Buy from $42 to $40 besides that on May-12-16 Pfizer Inc. (NYSE:PFE) was “Initiated” by Berenberg as Hold at $38. Furthermore on May-04-16 the stock was “Reiterated” by UBS as Buy from $36 to $38.

Pfizer Inc. (NYSE:PFE) shares ended last trading session at the price of $32.76 whereas a number of traders indicating mean target price will hit $39.40 over the next twelve months, mean value of price target most recently revised on 10/05/16. Pfizer Inc. (NYSE:PFE)’s highest estimates of price target are $54.00 and low forecast is $33.00 based on the opinion of 20 analysts. The price target estimates represents a standard deviation of 5.43. However brokerage recommendations suggests an ABR of 2.08 based on calls of 13 experts, where 6 brokers polls the stock a Strong Buy, 0 suggest the stock a Buy, 7 suggest Hold, 0 are rating the stock as Sell while 0 as Strong Sell.

Pfizer Inc. (NYSE:PFE) is expected to release the earnings of its current quarter on 11/1/16 Before Market Open. The company is expected to release $0.61 EPS for current quarter according to 17 analysts whereas the company reported $0.6 EPS during same quarter a year ago. For the current quarter the stock has a lowest EPS estimates of $0.57 and high estimate of $0.65. For the current year Pfizer Inc. (NYSE:PFE) has set to release EPS of $2.46 as per the sentiments of 18 analysts, however according to 21 analysts, the company expected to release $2.66 EPS for next year.

Pfizer Inc. (NYSE:PFE)’s average revenue estimates for the current quarter are $13.08B according to 14 number of analysts. However its lowest revenue estimates are $12.7B and highest revenue estimates are $13.44B. A year ago the company’s sales were $12.09B. Its yearly sales growth estimates are 8.20%. For the next quarter the company has anticipated average revenues of $13.75B, according to the sentiments of 14 analysts. For the current year the company has fixed $52.93B revenues, as per the opinion of 16 analysts. For the current year the company has low revenue estimates of $s52.29B in contradiction of high revenue estimates of $53.55B. Whereas for the next year revenues are set at $55.09B by 18 analysts.

The stock exchanged hands 23,688,600 shares versus average trading capacity of 19.02M shares, while its shares’ total market worth is $196.85B along with 6.07B outstanding shares. Pfizer Inc. (NYSE:PFE) shares were trading -11.65% below from the 52-week high price mark of $37.08 and +17.98% above from the 52-week price bottom of $27.77. However the company observed 52 week high price on 08/01/16 and witnessed 52 week low price on 02/08/16. The company’s price sits -4.83% below from its 50-day moving average of $34.08 and 0.21% far from the stock’s 200-day moving average which is $34.25. Pfizer Inc. (NYSE:PFE)’s price to sales ratio for trailing twelve month stands at 3.81, whereas its price to book ratio for most recent quarter sits at 3.17. However the company’s price to cash per share for most recent quarter stands at 9.51. Its price to free cash flow for trailing twelve months is 32.94.